Fox Allan M.
SEC CIK 1652936 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RGNX | REGENXBIO Inc. | Dir | 28.9K | — | $6.09M | 7 | 2021-09-17 | 2026-05-29 |
Most active insiders at RGNX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ciongoli Gregory Austin | Dir | $949.4K | — |
| 2 | PAKOLA STEVE | Chief Medical Off | — | $940.0K |
| 3 | Simpson Curran | CEO, Dir | — | $339.1K |
| 4 | Malzahn Craig | CTO | — | — |
| 5 | Bennett Jean | Dir | — | — |
| 6 | Chan Mitchell | CFO | — | — |
| 7 | Zachary Jennifer | Dir | — | — |
| 8 | Glucksmann Alexandra | Dir | — | — |
| 9 | Fox Allan M. | Dir | — | — |
| 10 | Mills Kenneth T. | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-02 17:15 | 2026-05-29 | RGNX | REGENXBIO Inc. | Fox Allan M. | Dir | A - Grant | $0.00 | +9,807 | 28.9K | +51% | $0 |
| D | 2025-06-03 | 2025-05-30 | RGNX | REGENXBIO Inc. | Fox Allan M. | Dir | A - Grant | $0.00 | +7,768 | 19.1K | +69% | $0 |
| D | 2024-06-04 | 2024-05-31 | RGNX | REGENXBIO Inc. | Fox Allan M. | Dir | A - Grant | $0.00 | +4,790 | 11.3K | +74% | $0 |
| D | 2023-06-06 | 2023-06-02 | RGNX | REGENXBIO Inc. | Fox Allan M. | Dir | A - Grant | $0.00 | +3,486 | 6,496 | +116% | $0 |
| D | 2022-06-07 | 2022-06-03 | RGNX | REGENXBIO Inc. | Fox Allan M. | Dir | A - Grant | $0.00 | +3,010 | 3,010 | New | $0 |
| MI | 2021-12-27 | 2021-12-22+ | RGNX | REGENXBIO Inc. | Fox Allan M. | Dir | S - Sale | $34.69 | -112.9K | 1.58M | -7% | -$3.92M |
| I | 2021-09-21 | 2021-09-17 | RGNX | REGENXBIO Inc. | Fox Allan M. | Dir | S - Sale | $45.04 | -48.2K | 1.36M | -3% | -$2.17M |
Purchase Sale Sale after option exercise All abbreviations